Associations of Pre-Transplant Prescription Narcotic Use with Clinical Complications after Kidney Transplantation

Background: The impact of narcotic use before kidney transplantation on post-transplant clinical outcomes is not well described. Methods: We examined integrated national transplant registry, pharmacy records, and Medicare billing claims to follow 16,322 kidney transplant recipients, of whom 28.3% filled a narcotic prescription in the year before transplantation. Opioid analgesic fills were normalized to morphine equivalents (ME) and expressed as mg/kg exposures (approximate quartiles: 0.1-1.7, 1.8-5.4, 5.5-23.7, and ≥23.8 mg/kg, respectively). Post-transplant cardiovascular, respiratory, neurological, accidents, substance abuse, and noncompliance events were identified using diagnosis codes on Medicare billing claims. Adjusted associations of ME level with post-transplant complications were quantified by multivariate Cox regression. Results: The incidence of complications at 3 years post-transplant among those with the highest pre-transplant ME exposure compared to no use included: ventricular arrhythmias, 1.1 vs. 0.2% (p < 0.001); cardiac arrest, 4.7 vs. 2.7% (p < 0.05); hypotension, 14 vs. 8% (p < 0.0001); hypercapnia, 1.6 vs. 0.9% (p < 0.05); mental status changes, 5.3 vs. 2.7% (p < 0.001); drug abuse/dependence, 7.0 vs. 1.7% (p < 0.0001); alcohol abuse, 1.8 vs. 0.6% (p = 0.0001); accidents, 0.9 vs. 0.3% (p < 0.05); and noncompliance, 3.5 vs. 2.3% (p < 0.05). In multivariate analyses, transplant recipients with the highest level of pre-transplant narcotic use had approximately 2 to 4 times the risks of post-transplant ventricular arrhythmias, mental status changes, drug abuse, alcohol abuse, and accidents compared with non-users, and 35-45% higher risks of cardiac arrest and hypotension. Conclusion: Although associations may reflect underlying conditions or behaviors, high-level prescription narcotic use before kidney transplantation predicts increased risk of clinical complications after transplantation.

[1]  M. Schnitzler,et al.  Quantifying Prognostic Impact of Prescription Opioid Use Before Kidney Transplantation Through Linked Registry and Pharmaceutical Claims Data , 2015, Transplantation.

[2]  T. Gomes,et al.  Trends in high-dose opioid prescribing in Canada. , 2014, Canadian family physician Medecin de famille canadien.

[3]  E. Manias,et al.  Medicine non-adherence in kidney transplantation. , 2014, Journal of renal care.

[4]  T. Brennan,et al.  Abusive prescribing of controlled substances--a pharmacy view. , 2013, The New England journal of medicine.

[5]  F. Luan,et al.  A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk. , 2013, Kidney international.

[6]  T. Farley,et al.  Opioid analgesics--risky drugs, not risky patients. , 2013, JAMA.

[7]  T. Farley,et al.  Guidelines for Opioid Prescription: Why Emergency Physicians Need Support , 2013, Annals of Internal Medicine.

[8]  Matt Schiller,et al.  A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. , 2012, Pain medicine.

[9]  Laxmaiah Manchikanti,et al.  Opioid epidemic in the United States. , 2012, Pain physician.

[10]  M. Nowicki,et al.  Similar prevalence but different characteristics of pain in kidney transplant recipients and chronic hemodialysis patients , 2011, Clinical transplantation.

[11]  C. Henderson,et al.  Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes. , 2010, Pain medicine.

[12]  M. Schnitzler,et al.  Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  L. Fishman,et al.  Changing practice to improve pain control for renal patients , 2009, Postgraduate Medical Journal.

[14]  E. Lerut,et al.  Acute rejection in non‐compliant renal allograft recipients: a distinct morphology , 2007, Clinical transplantation.

[15]  K. Denhaerynck,et al.  Prevalence and Risk Factors of Non‐Adherence with Immunosuppressive Medication in Kidney Transplant Patients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  A. Moss,et al.  Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease. , 2006, Journal of the American Society of Nephrology : JASN.

[17]  M. Fine,et al.  Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. , 2005, Journal of the American Society of Nephrology : JASN.

[18]  Eija Kalso,et al.  Opioids in chronic non-cancer pain: systematic review of efficacy and safety , 2004, Pain.

[19]  M. Dean.  Opioids in renal failure and dialysis patients. , 2004, Journal of pain and symptom management.

[20]  Evelyne Lerut,et al.  Prospective Study on Late Consequences of Subclinical Non‐Compliance with Immunosuppressive Therapy in Renal Transplant Patients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  S. Davison.  Pain in hemodialysis patients: prevalence, cause, severity, and management. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  G. Chertow,et al.  Analgesia in patients with ESRD: a review of available evidence. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  H. S. Lau,et al.  Validation of pharmacy records in drug exposure assessment. , 1997, Journal of clinical epidemiology.

[24]  S. Geest,et al.  INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS , 1995, Transplantation.

[25]  Fred H. Wiman,et al.  Recording of drug prescriptions in the county of Jämtland, Sweden , 1977, European Journal of Clinical Pharmacology.

[26]  M. Valenstein,et al.  Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths , 2012 .

[27]  Paul Grootendorst,et al.  Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. , 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[28]  G. Boethius.  Recording of drug prescriptions in the county of Jämtland, Sweden. II. Drug exposure of pregnant women in relation to course and outcome of pregnancy. , 1977, European journal of clinical pharmacology.